Clinical Practice Committee

Lewis B. Holmes, MD, Chair
The Clinical Practice Committee of the ACMG focuses on issues of concern to practicing clinical geneticists. In discussions and position statements we have addressed Cystic Fibrosis (CF) screening, the addition of screening for Canavan's disease to Tay Sachs screening, and genetic screening in general. We have published our position statements about the lack of apparent benefit from treating children with Down syndrome with Piracetam and nutrition supplements. The Dysmorphology Subcommittee (Chris Cunniff, MD, Chair) has developed and published suggestions for the work-up of individuals with mental retardation. Currently, they are developing guidelines for the evaluation of the stillborn infant. The a-fetoprotein (AFP) and Related Analytes Subcommittee (Ira Salafsky, MD, Chair) has developed commentaries on folic acid supplementation and is now addressing the issue of genetic screening in the first trimester.
Laboratory Practice Committee
Michael S. Watson, PhD, Chair
The Laboratory Practice Committee has initiated several new projects. After the NIH Cystic Fibrosis Consensus Conference, it was immediately recognized that testing for CF mutations is relatively straightforward, but that the delivery system of screening parents for carrier status in primary care settings is not fully developed. A mechanism for providing the full spectrum of services with CF carrier screening tests was needed. This activity is being included under a new committee chaired by Robert Desnick, MD, PhD. This committee is also facilitating the transfer of new tests and technologies into clinical investigation and practice, ensuing development of guidelines for analytic components of tests, billing and reimbursement issues, regulatory agency interaction, etc.
Quality Assurance Subcommittee
Shivanand Patil, PhD and C. Sue Richards, PhD, Co-chairs
The Quality Assurance Subcommittee of the Laboratory Practice Committee has been responsible for the develop ment and maintenance of the "Standards and Guidelines for Clinical Genetics Laboratories." First published in 1994, the manual is going into its second edition. This edii tion will address the limited number of concerns expressed by members and will add a new section on the interphase and metaphase fluorescence in situ hybridiz* tion (FISH) testing and several methods in molecular genetic testing. The College's Standards and Guidelines have been used by laboratories as part of their quality assurance programs and by regulatory bodies in the deveg opment of their requirements for genetic laboratories.
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